(Q48477274)

English

Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial.

scientific article published on 8 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

E Del Fabbro

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

J M Garcia

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

R Dev

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

D Hui

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

J Williams

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

D Engineer

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

J L Palmer

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

L Schover

8

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

E Bruera

9

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

publication date

8 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

21

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

9

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

2599-2607

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

https://scigraph.springernature.com/pub.10.1007/s00520-013-1832-5

0 references

The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Associations among hypogonadism, C-reactive protein, symptom burden, and survival in male cancer patients with cachexia: a preliminary report

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: evaluation by IIEF score

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Testosterone supplementation improves spatial and verbal memory in healthy older men.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Validation of the Edmonton Symptom Assessment Scale.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Construct validation of the hospital anxiety and depression scale with clinical populations.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

The sexual desire inventory: development, factor structure, and evidence of reliability.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Effects of progressive strength training on the performance of the Functional Reach Test and the Timed Get-Up-and-Go Test in an elderly population from the rural north of Portugal.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

The determination of bio-available testosterone

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Hypogonadism in male patients with cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Effects of graded doses of testosterone on erythropoiesis in healthy young and older men.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Identification of factors associated with fatigue in advanced cancer: a subset analysis of the European palliative care research collaborative computerized symptom assessment data set.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Effects of red blood cell transfusion on anemia-related symptoms in patients with cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

The advantages and limitations of cross-sectional body composition analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Brouhaha erupts over testosterone-testing advertising campaign

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1832-5

21 January 2018

Validation of a screening questionnaire for androgen deficiency in aging males

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The association between anemia and fatigue in patients with advanced cancer receiving palliative care

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypogonadism in male patients with metastatic cancer prior to chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Edmonton Symptom Assessment System (ESAS): A Simple Method for the Assessment of Palliative Care Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between megestrol acetate treatment and symptomatic adrenal insufficiency with hypogonadism in male patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of the functional assessment of chronic illness therapy-fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Precision and reliability of strength (Jamar vs. Biodex handgrip) and body composition (dual-energy X-ray absorptiometry vs. bioimpedance analysis) measurements in advanced cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sex, health, and years of sexually active life gained due to good health: evidence from two US population based cross sectional surveys of ageing

1 reference

https://pubmed.ncbi.nlm.nih.gov/23653013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-013-1832-5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

release_6y7iany3jvegbkggoqbpu26z74

1 reference

https://api.fatcat.wiki/v0/release/6y7iany3jvegbkggoqbpu26z74

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23653013

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48477274&oldid=1835367312"